4931423N10Rik Inhibitors
Chemicals that fall into the category of Potegl Inhibitors do not directly target the POTEG protein. Instead, they encompass a diverse group of compounds that are capable of influencing various cellular pathways potentially connected to the biological function of POTEG. These compounds share the common characteristic of modulating specific enzymes or signaling molecules that are upstream or downstream of POTEG. For example, inhibitors like wortmannin and LY294002 target the PI3K/Akt pathway, which is a critical signaling pathway in many cellular processes. By inhibiting this pathway, these compounds can indirectly affect the function of POTEG, although the precise mechanisms remain uncharacterized. Similarly, rapamycin targets the mTOR pathway, another key regulator of cell growth and metabolism, which could intersect with POTEG-related signaling.
The chemical inhibitors listed include kinase inhibitors, such as U0126, which targets MEK, and SB203580, which targets p38 MAPK, both of which are part of the MAPK signaling cascade. This cascade is a crucial regulator of cell differentiation, proliferation, and survival. Dasatinib and PP2 are Src family kinase inhibitors, highlighting the importance of tyrosine kinase signaling in numerous cellular processes that might be relevant to POTEG's role.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Akt pathway inhibitor; by inhibiting PI3K, which is upstream of Akt, this compound can reduce the phosphorylation and activation of downstream proteins potentially regulated by the POTEG protein. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor; this molecule can decrease the activation of the PI3K-Akt signaling pathway, which may be related to the function of POTEG, thereby potentially affecting its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; since mTOR is a downstream target of PI3K/Akt signaling, inhibiting mTOR can have effects on the proteins and processes that are regulated by the POTEG protein. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor; by inhibiting MEK, this compound can affect the MAPK/ERK pathway, which might intersect with POTEG-related signaling, altering the function of the protein. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor; it can affect the p38 MAPK pathway, potentially influencing the cascade of events that POTEG might be involved in. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor; this chemical can hinder the JNK signaling pathway, which may intersect with POTEG-related processes, thereby influencing its function. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src family kinases inhibitor; as Src kinases can be involved in multiple signaling pathways, inhibiting these kinases can affect processes and proteins that are regulated by POTEG. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Another Src family kinase inhibitor; this compound can alter the activity of Src family kinases, potentially influencing POTEG-related signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Erk inhibitor; as it selectively inhibits MEK activation, it can modulate the ERK pathway, potentially affecting POTEG function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor; by inhibiting the proteasome, this compound can affect protein degradation pathways, potentially altering the levels of proteins that interact with or are regulated by POTEG. | ||||||